Castle Biosciences (CSTL) Earnings Date & Reports

A.I. Advisor

published Earnings

CSTL is expected to report earnings to fall 142.87% to -13 cents per share on November 11

Castle Biosciences CSTL Stock Earnings Reports

Q3'24

Est.

$-0.13

Q2'24

Beat

by $0.58

Q1'24

Beat

by $0.23

Q4'23

Beat

by $0.48

Q3'23

Beat

by $0.50

The last earnings report on August 05 showed earnings per share of 31 cents, beating the estimate of -27 cents. With 280.57K shares outstanding, the current market capitalization sits at 608.02M.

View a ticker or compare two or three

Compare

CSTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CSTL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CSTL (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

N/A

Address

505 South Friendswood Drive

Phone

+1 866 788-9007

Employees

610

Web

https://www.castlebiosciences.com